Key result
VASP phosphorylation reduces myocardial ischemia-reperfusion injury by preventing platelet-neutrophil complex formation.
Why the study?
Does phosphorylation of Vasodilator-Stimulated Phosphoprotein prevent platelet-neutrophil complex formation and dampen myocardial ischemia-reperfusion injury?
Does phosphorylation of Vasodilator-Stimulated Phosphoprotein prevent platelet-neutrophil complex formation and dampen myocardial ischemia-reperfusion injury?
Phosphorylation of VASP plays a previously unappreciated and crucial role in preventing platelet-neutrophil complex formation and reducing myocardial ischemia-reperfusion injury.
VASP phosphorylation may limit myocardial IR injury via PNCs in animals; leaves open translation to human reperfusion therapy.
Previously unappreciated, the phosphorylation of VASP performs a key function for the formation of PNCs that is crucially important for the extent of myocardial IR injury.
No takes yet. Share an insight, caveat, or question.
Köhler et al. (2011) studied this question. Phosphorylation of vasodilator-stimulated phosphoprotein prevents platelet-neutrophil complex formation and dampens myocardial ischemia-reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: